Skip to content
Screener

Net Income at other companies

Eli Lilly logo
Eli LillyLLY
$7.1B+25.3%
Amgen logo
AmgenAMGN
$2.38B+65.9%
Altimmune logo
AltimmuneALT
-$22.56M-15.3%
Viking Therapeutics logo
Viking TherapeuticsVKTX
-$158.33M-247%
Wave Life Sciences logo
Wave Life SciencesWVE
-$69.36M-37.4%
Prime Medicine logo
Prime MedicinePRME
-$42.11M+19.9%

Segments

By segment

See full
Biopharm Division-$6.15M+3.3%
Neurostimulation Division-$216K

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.9M+7.9%
EPS (diluted)-$0.07+41.7%

Balance sheet

See full
Cash & equivalents$18.6M+221%
Total debt$17.9M-4.1%
Total equity$19.0M+286%
Total assets$41.6M+44.1%

Cash flow

See full
Operating cash flow-$6.0M+0.9%
CapEx$99.0K+39.4%
Free cash flow-$6.1M+0.4%

Valuation

See full
Market cap$127.64M+76.6%
Enterprise value$126.85M+49.1%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-220.4%+69.6pp
Debt / equity0.9×-2.8×
Current ratio3.2×+2.0×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: Vivani Medical’s 10-Q, filed August 13, 2026.

Filed
Aug 13, 2026, 4:01 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001753926-26-001477
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Research and development, net of grants$4,456$4,759$8,957$8,976
General and administrative, net of grants2,4182,7034,8645,044
Total operating expenses6,8747,46213,82114,020
Loss from operations(6,874)(7,462)(13,821)(14,020)
Other income, net504318671574
Net loss$(6,370)$(7,144)$(13,150)$(13,446)
Net loss per common share - basic and diluted$(0.07)$(0.12)$(0.16)$(0.23)
Weighted average shares outstanding - basic and diluted87,09059,24484,19659,240

Document

FAQ

What is Vivani Medical's net income?
Vivani Medical (VANI) reported net income of -$6.37M in Q2 2026.
How has Vivani Medical's net income changed year-over-year?
Vivani Medical's net income increased by 10.8% year-over-year, from -$7.14M to -$6.37M.
What is the long-term trend for Vivani Medical's net income?
Over 4 years (2021 to 2025), Vivani Medical's net income has grown at a 26.4% compound annual growth rate (CAGR), from -$10.44M to -$26.61M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Ask your AI about Vivani Medical's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude